CONTROLLED CLINICAL TRIAL OF 4-4 DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
D000293:Adolescent; D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D044466:Asian People; D001431:Bacteriological Techniques; D035843:Biomedical Research; D001774:Blood Chemical Analysis; D002681:China; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D005000:Ethionamide; D007408:Intestinal Absorption; D007538:Isoniazid; D010670:Phenylthiourea / Q000031:analogs & derivatives; D013902:Radiography, Thoracic; D013183:Sputum; D013307:Streptomycin; D013882:Thiosemicarbazones; D014116:Toxicology; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013882:Thiosemicarbazones; C100189:thiocarlide; D010131:Aminosalicylic Acid; D010670:Phenylthiourea; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
ADOLESCENCE; AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNICS; BLOOD CHEMICAL ANALYSIS; CHINA; CLINICAL RESEARCH; DRUG RESISTANCE, MICROBIAL; ETHIONIAMIDE; INTESTINAL ABSORPTION; ISONIAZID; MONGOLOID RACE; SPUTUM; STREPTOMYCIN; THIOCARLIDE; THIOSEMICARBAZONES; THORACIC RADIOGRAPHY; TOXICOLOGIC REPORT